Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS(G12C) inhibitors. Riedl JM, Fece de la Cruz F, Lin JJ, Parseghian C, et al. Ann Oncol 2025;36:682-692.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Riedl JM, Fece de la Cruz F, Lin JJ, Parseghian C, et al. Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS(G12C) inhibitors. Ann Oncol 2025;36:682-692.
PMID: 39914665